Article
Patients younger than forty years old with hepatitis C virus genotype-1 chronic infection had treatment responses similar to genotype-2 infection and not related to interleukin-28B polymorphism.
Annals of hepatology - 1 Jan 2000
Lin Chun-Yen, Sheen I-Shyan, Jeng Wen-Juei, Huang Chang-Wen, Huang Chien-Hao, Chen Ji-Yih
Abstract excerpt
BACKGROUND AND RATIONALE: Age is one of the predictors for sustained virological response (SVR) when treating chronic hepatitis C (CHC) patients with pegylated-interferon/ribavirin (PegIFN/RBV). However, the treatment responses of the young patients had not been analyzed before. Therefore, we conducted this study to investigate the treatment responses of CHC patients younger than 40 years old (y/o). MATERIAL AND...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.